Literature DB >> 19756389

Cell death and stress signaling in glycogen storage disease type I.

So Youn Kim1, Yun Soo Bae.   

Abstract

Cell death has been traditionally classified in apoptosis and necrosis. Apoptosis, known as programmed cell death, is an active form of cell death mechanism that is tightly regulated by multiple cellular signaling pathways and requires ATP for its appropriate process. Apoptotic death plays essential roles for successful development and maintenance of normal cellular homeostasis in mammalian. In contrast to apoptosis, necrosis is classically considered as a passive cell death process that occurs rather by accident in disastrous conditions, is not required for energy and eventually induces inflammation. Regardless of different characteristics between apoptosis and necrosis, it has been well defined that both are responsible for a wide range of human diseases. Glycogen storage disease type I (GSD-I) is a kind of human genetic disorders and is caused by the deficiency of a microsomal protein, glucose-6-phosphatase-α (G6Pase-α) or glucose-6-phosphate transporter (G6PT) responsible for glucose homeostasis, leading to GSD-Ia or GSD-Ib, respectively. This review summarizes cell deaths in GSD-I and mostly focuses on current knowledge of the neutrophil apoptosis in GSD-Ib based upon ER stress and redox signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756389     DOI: 10.1007/s10059-009-0126-8

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  5 in total

Review 1.  Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?

Authors:  David S Hill; Penny E Lovat; Nikolas K Haass
Journal:  Melanoma Manag       Date:  2014-12-04

2.  Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.

Authors:  Zollie A Yavarow; Hye-Ri Kang; Lauren R Waskowicz; Boon-Huat Bay; Sarah P Young; Paul M Yen; Dwight D Koeberl
Journal:  Hum Mol Genet       Date:  2020-01-15       Impact factor: 6.150

3.  Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.

Authors:  Lauren R Waskowicz; Jin Zhou; Dustin J Landau; Elizabeth D Brooks; Andrea Lim; Zollie A Yavarow; Tsubasa Kudo; Haoyue Zhang; Yajun Wu; Stuart Grant; Sarah P Young; Bay Boon Huat; Paul M Yen; Dwight D Koeberl
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

4.  Pseudomonas aeruginosa exotoxin A reduces chemoresistance of oral squamous carcinoma cell via inhibition of heat shock proteins 70 (HSP70).

Authors:  Sang Rye Park; Kyoung Duk Lee; Uk Kyu Kim; Young Gi Gil; Kyu Seon Oh; Bong Soo Park; Gyoo Cheon Kim
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 3.052

5.  Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia.

Authors:  Hye-Ri Kang; Lauren Waskowicz; Andrea M Seifts; Dustin J Landau; Sarah P Young; Dwight D Koeberl
Journal:  Mol Ther Methods Clin Dev       Date:  2019-02-10       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.